Impressum
Kundeninformation
| |
|
|||
Encyclopedia of Cancer |
Kontakt/Bestellung |
|
3rd Edition Hrsg. v. Paolo Boffetta und Pierre Hainaut |
|
|
Online |
|
|
Inhalt :: Content Umfassendes Referenzwerk mit über 180 ausführlichen, von führenden internationalen Fachwissenschaftlern und Experten verfassten Beiträgen zur Onkologie und Krebsforschung. Behandelt werden die neuesten Entwicklungen in den Bereichen Mechanismen, Charakteristika von Krebs, Krebsursachen, Prävention und Kontrolle, Diagnose und Therapie, Pathologie und Genetik bestimmter Krebsarten. |
|
|
Verlag :: Publisher Elsevier Science |
|
|
Preis :: Price Preise auf Anfrage / Prices on request |
|
|
Das Angebot richtet sich nicht an Verbraucher i. S. d. § 13 BGB und Letztverbraucher i. S. d. PAngV. |
|
|
ISBN/ISSN 978-0-12-812485-7 Bestellnummer bei digento :: digento order number 10226094 |
|
|
Verlagsinformation :: Publisher's information Encyclopedia of Cancer, Third Edition provides a comprehensive, up-to-date overview of the multiple facets of the disease, including research, treatment and societal impact. This new edition comprises 180 contributions from renown experts who present the latest in Mechanisms, Hallmarks of Cancer, Causes of Cancer, Prevention and Control, Diagnosis and Therapy, Pathology and the Genetics of specific Cancers. Readers will find a comprehensive overview of the main areas of oncology, including etiology, mechanisms, prevention, and treatments, from basic science to clinical applications and public health, all set alongside the latest advances and hot topics that have emerged since the previous edition. Topics of interest in the field, including genomics and epigenomics, our understanding of the causes of cancer and the approaches to preventing it (e.g., HPV vaccination, role of obesity and nutrition, molecular markers of environmental exposures), new screening techniques (e.g., low-dose CT for lung cancer) and improvements in the treatment of many cancers (e.g., breast cancer, lung adenocarcinoma) are comprehensively and authoritatively presented. Key Features
Readership Oncologists; cancer researchers; oncology fellows in training; students and researchers in biology and epidemiology. Medical doctors other than oncologists and other cancer-related medical professionals will also benefit |
|
